EUVIMEDEUVIMED entdecken
Crossref

Tafamidis may Stabilise Progression of Atrial Myopathy in Transthyretin Cardiac Amyloidosis

A. Boyd, P. Geenty, J. Pham, P. Emerson, L. Thomas

Heart, Lung and Circulation · 2026-08 · 35 · S183

DOI: 10.1016/j.hlc.2026.07.201 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Heart, Lung and Circulation, 2026-08. Verfasst von A. Boyd und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Boyd, A., Geenty, P., Pham, J., Emerson, P., & Thomas, L. (2026). Tafamidis may Stabilise Progression of Atrial Myopathy in Transthyretin Cardiac Amyloidosis. Heart, Lung and Circulation, 35, S183. https://doi.org/10.1016/j.hlc.2026.07.201

Vancouver

Boyd A, Geenty P, Pham J, Emerson P, Thomas L. Tafamidis may Stabilise Progression of Atrial Myopathy in Transthyretin Cardiac Amyloidosis. Heart, Lung and Circulation. 2026;35:S183. doi:10.1016/j.hlc.2026.07.201

BibTeX
@article{Boyd2026,
  author = {Boyd, A. and Geenty, P. and Pham, J. and Emerson, P. and Thomas, L.},
  title = {Tafamidis may Stabilise Progression of Atrial Myopathy in Transthyretin Cardiac Amyloidosis},
  journal = {Heart, Lung and Circulation},
  year = {2026},
  volume = {35},
  pages = {S183},
  doi = {10.1016/j.hlc.2026.07.201}
}
Kostenlos starten →